EMEA-000409-PIP01-08-M05

Key facts

Invented name
Tivicay
Active substance
dolutegravir
Therapeutic area
Infectious diseases
Decision number
P/0017/2019
PIP number
EMEA-000409-PIP01-08-M05
Pharmaceutical form(s)
  • Age appropriate formulation for oral use
  • Tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
ViiV Healthcare UK Ltd.

United Kingdom
E-mail: eu.paediatric-plans@gsk.com
Tel. +44 (0)20 8966 3650
Fax +44 (0)20 8990 3511

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating